Obstructive sleep apnoea-hypopnoea syndrome and arterial hypertension

Acta Cardiologica

Volumn 61, Issue 1, 2006, Pages 95-102

  Van Meerhaeghe, Alain ^a   Moscariello, Antonio ^a   Velkeniers, Brigitte ^b  

^a CHU Andre Vesale   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Continuous positive airway pressure; Hypertension; Ocstructive sleep apnoea hypopnoea

Indexed keywords

HEART RATE; HUMAN; HYPERTENSION; NONREM SLEEP; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; REVIEW; SLEEP APNEA SYNDROME; SYMPATHETIC TONE; VENOUS RETURN;

CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 32044471114     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.61.1.2005146     Document Type: Review

References (84)

1. Findley LJ, Levinson MP, Bonnie RJ. Driving performance and automobile accidents in patients with sleep apnea. Clin Chest Med 1992; 13: 427-35.
2. Isono S, Remmers JE, Tanaka A, Sho Y, Sato J, Nishino T. Anatomy of pharynx in patients with obstructive sleep apnea and in normal subjects. J Appl Physiol 1997; 82: 1319-26.
3. Schwab RJ, Pasirstein M, Pierson R, Mackley A, Hachadoorian R, Arens R, Maislin G, Pack AI. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med 2003; 168: 522-30.
4. Fogel RB, Malhotra A, Pillar G, Edwards JK, Beauregard J, Shea SA, White DP. Genioglossal activation in patients with obstructive sleep apnea versus control subjects. Mechanisms of muscle control. Am J Respir Crit Care Med 2001; 164: 2025-30.
5. Hosselet J, Ayappa I, Norman RG, Krieger AC, Rapoport DM. Classification of sleep-disordered breathing. Am J Respir Crit Care Med 2001; 163: 398-405.
6. Meoli AL, Casey KR, Clark RW, Coleman JA Jr, Fayle RW, Troell RJ, Iber C; Clinical Practice Review Committee. Hypopnea in sleep-disordered breathing in adults. Sleep 2001; 24: 469-70.
7. Flemons WW, Whitelaw WA, Brant R, Remmers JE. Like-lihood ratios for a sleep apnea clinical prediction rule. Am J Respir Crit Care Med 1994; 150: 1279-85.
8. Flemons WW, Mc Nicolas WT. Clinical prediction of the sleep apnea syndrome. Sleep Med Rev 1997; 1: 19-32.
9. Peppard P. A population-based longitudinal epidemiologic study of the association of sleep-disordered breathing with body habitus and elevated blood pressure. Doctoral dissertation, Department of Preventive Medicine, University of Wisconsin-Madison, Madison, WI; 1999: p. 219.
10. Schwab RJ. Upper airway imaging. Clin Chest Med 1998; 19: 33-54.
11. Mirza N, Lanza DC. The nasal airway and obstructed breathing during sleep. Otolaryngol Clin North Am 1999; 32: 243-62.
12. Wetter DW, Young TB, Bidwell TR, Badr MS, Palta. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med 1994; 154: 2219-24.
13. Bresnitz EA, Goldberg R, Kosinski RM. Epidemiology of obstructive sleep apnea. Epidemiol Rev 1994; 16: 210-27.
14. Grunstein RR, Sullivan CE. Neural control of respiration during sleep. In: Thory Mj, ed. Handbook of sleep disorders. Marcel Dekker; New York, 1990. pp.77-102.
15. Chesson AL, Ferber RA, Fry JM, Grigg-Damberger M, Hartse KM, Hurwitz TD, Johnson S, Kader GA, Littner M, Rosen G, Sangal RB, Schmidt-Nowara W, Sher A. The indications for polysomnography and related procedures. Sleep 1997; 20: 423-487.
16. Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Rein J, Vela-Bueno A, Kales A. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001; 163: 608-13.
17. Duran J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001; 163: 685-89.
18. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165: 1217-39.
19. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-5.
20. He J, Kryger MH, Zorick FJ. Mortality and apnea index in obstructive sleep apnea: experience in 385 male patients. Chest 1988; 94: 9-14.
21. Lavie P, Herer P, Peled R, Berger I, Yoffe N, Zomer J, Rubin AH. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 1995; 18: 149-57.
22. Marin JM, Santiago JC, Vincente E, Augusti AGN. Long-term cardiovascular outcomes in men with obstructive sleep-apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-53.
23. Shamsuzzaman A, Gersh B, Somers VK. Obstructive sleep apnea. Implications for cardiac and vascular disease. JAMA 2003; 290: 1906-14.
24. Shabari Y, Scope A, Chorney N, Grotto I, Dagan Y. Diastolic blood pressure is the first to rise in association with early subclinical obstructive sleep apnea: lessons from periodic examination screening. Am J Hypertens 2003; 16: 236-9.
25. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, Pickering TG for the Sleep Heart Health Study. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000; 283: 1829-36.
26. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320: 479-82.
27. Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Leiby BE, Vela-Bueno A, Kales A. Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000; 160: 2289-95.
28. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-84.
29. Garcia-Rio F, Pino JM, Alonso A, Arias MA, Martinez I, Alvaro D, Villamor J. White coat hypertension in patients with obstructive sleep apnea-hypopnea syndrome. Chest 2004; 125: 817-22.
30. Ventura HO, Mehra MR. White coat hypertension and sleep apnea. Is there a link? Chest 2004; 125: 805-6.
31. Bidlingmeyer I, Burnier M, Bidlingmeyer M, Waeber B, Brunner HR. Isolated office hypertension: a prehypertensive state? J Hypertens 1996; 14: 327-32.
32. Bjorklund K, Lind L, Vessby B, Andren B, Lithell H. Different metabolic predictors of white coat and sustained hypertension over a 20-year follow-up period: a population based study of elderly men. Circulation 2002; 106: 63-8.
33. Quan SF, Bersh BJ. Cardiovascular consequences of sleep-disordered breathing: past, present, and future. Report of a workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, Blood Institute. Circulation 2004; 109: 951-7.
34. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 1993; 328: 303-7.
35. Kimoff RJ, Makino H, Horner RL, Kozar LF, Lue F, Slutsky AS, Phillipson EA. Canine model of obstructive sleep apnea: model description and preliminary application. J Appl Physiol 1994; 76: 1810-7.
36. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension: evidence from a canine model. J Clin Invest 1997; 99: 106-9.
37. Fletcher EC. Obstructive sleep apnoea and cardiovascular death: cause-effect? Monaldi Arch Chest Dis 1995; 50: 340-1.
38. nd ed. Marcel Dekker; New York, 1994: p. 823-46.
39. Narkiewicz K, van de Borne PJ, Pesek CA, Dyken ME, Montano N, Somers VK. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 1999; 99: 1183-9.
40. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897-904.
41. Guilleminault C, Robinson A. Sleep-disordered breathing and hypertension: past lessons, future directions. Sleep 1997; 20: 806-11.
42. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 1999; 17: 61-6.
43. Carlson JT, Rangemark C, Hedner JA. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertension 1996; 14: 577-84.
44. Schulz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lucke C, Mayer K, Olchewsski H, Seeger W, Grimminger F. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000; 55: 1046-51.
45. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002; 165: 677-82.
46. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354: 1435-9.
47. Lanfranco TF, Gianotti L, Pivetti S, Navone F, Rossetto R, Grottoli S, Gai V, Ghigo E, Maccario M. Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables. Clin Endocrinol 2003; 59: 374-9.
48. Bratel T, Wennlund A, Carlstrom K. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnea: effects of continuous positive airway pressure treatment (CPAP). Respir Med 1999; 93: 1-7.
49. Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea; Facts and theory. Am J Med 1995; 98: 118-28.
50. Morgan BJ, Crabtree DC, Puleo MS, Badr MS, Toiber F, Skatrud JB. Neurocirculatory consequences of abrupt change in sleep state in humans. J Appl Physiol 1996; 80: 1627-36.
51. Silverberg DS, Iaina A. Treating obstructive sleep apnea improves essential hypertension and quality of life. Am Fam Physician 2002; 65: 229-36.
52. Lavie P, Ben-Yosef R, Rubin AE. 1984. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J 1984; 108: 373-6.
53. rd, Locke TW, Vela-Bueno A, Soldatos CR. Sleep apnoea in a hypertensive population. Lancet 1984; 2: 1005-8.
54. Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, Leung RS, Bradley TD. High prevalence of unrecognised sleep apnoea in drug-resistant hypertension. J Hypertens 2011; 19: 2271-7.
55. Lavie P, Hoffstein V. Sleep apnea syndrome: a possible contributing factor to resistant hypertension. Sleep 2001; 24: 721-5.
56. Man GC. Obstructive sleep apnea. Diagnosis and treatment. Med Clin North Am 1996; 80: 803-20.
57. Peppard PE, Young T, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000; 284: 3015-21.
58. Sampol G, Munoz X, Sagales MT, Marti S, Roca A, Dolors de la Cazalda M, Lloberes P, Morell F. Long-term efficacy of dietary weight loss in sleep apnoea/hypopnoea syndrome. Eur Respir J 1998; 12: 1156-9.
59. Rasheid S, Banasiak M, Gallagher SF, Lipska A, Kaba S, Ventimiglia D, Anderson WM, Murr MM. Gastric bypass is an effective treatment for obstructive sleep apnea in patients with clinically significant obesity. Obes Surg 2003; 13: 58-61.
60. Valencia-Flores M, Orea A, Herrera M, Santiago V, Rebollar V, Castano VA, Oseguera J, Pedroza J, Sumano J, Resendiz M, Garcia-Ramos G. Effect of bariatric surgery on obstructive sleep apnea and hypopnea syndrome, electrocardiogram, and pulmonary arterial pressure. Obes Surg 2004; 14: 755-62.
61. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-37.
62. Waradekar NV, Sinoway LI, Zwillich CW, Leuenberger UA. Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 1996; 153, 1333-8.
63. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998; 98: 772-6.
64. Heitmann J, Elhenz K, Penzel T, Becker HF, Grote L, Voigt KH, Peter JH, Vogelmeier C. Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J 2004; 23: 255-62.
65. Ito R, Hamada H, Yokoyama A, Oshima M, Katayama H, Ohnishi H, Kadowaki T, Ishimaru S, Irufine K, Higaki J. Successful treatment of obstructive sleep apnea syndrome improves autonomic nervous system dysfunction. Clin Exp Hypertens 2005; 27: 259-67.
66. Becker HF, Jerrentrup A, Ploch T, Grote L, Penzl T, Sullivan CE, Peter JH. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 20003; 107: 68-73.
67. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 1999; 17: 61-6.
68. Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC, Lam WK. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continous positive airway pressure. Am J Respir Crit Care Med 2000; 162: 2166-71.
69. Ohike Y, Kozaki K, Eto M, Ohga E, Santa T, Imai K, Hashimoto M, Yoshizumi M, Ouchi Y Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure - possible involvement of nitric oxide and asymmetric NG-dimethylarginine. Circ J 2005; 69: 221-6.
70. Smurra M, Philip P, Guilleminault C, Bioulac B, Gin H. CPAP treatment does not affect glucose-insulin metabolism in sleep apneic patients. Sleep Med 2001; 2: 207-13.
71. Brooks B, Cistulli PA, Borkman M, Ross G, McGhee S, Grunstein RR, Sullivan CE, Yue DK. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994; 79: 1681-5.
72. Tasali E, Van Cauter E. Sleep-disordered breathing and the current epidemic of obesity: consequence or contributing factor? Am J Respir Crit Care Med 2002; 165: 562-3.
73. Suzuki M, Otsuka K, Guilleminault C. Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients. Sleep 1993; 16: 545-9.
74. Voogel AJ, van Steenwijk RP, Karemaker JM, van Montfrans GA. Effects of treatment of obstructive sleep apnea on circadian hemodynamics. J Auton Nerv Syst 1999; 77: 177-83.
75. Jennum P, Wildschiodtz G, Christensen NJ, Schwartz T. Blood pressure, catecholamines, and pancreatic polypeptide in obstructive sleep apnea with and without nasal continuous positive airway pressure (nCPAP) treatment. Am J Hypertens 1989; 2: 847-52.
76. Wilcox I, Grunstein RR, Hedner JA, Doyle J, Collins FL, Fletcher PJ, Kelly DT, Sullivan CE. Effect of nasal continuous positive airway pressure during sleep on 24-h blood pressure in obstructive sleep apnea. Sleep 1993; 16: 539-44.
77. Tun Y, Wataru H, Shinichi O, Ogawa H, Kikuchi Y, Oikawa M, Kitamuro T, Shirato K. Can nasal continuous positive airway pressure decrease clinic blood pressure in patients with obstructive sleep apnea? Tohoku J Exp Med 2003; 201: 181-90.
78. Hermida RC, Zamarron C, Ayala DE, Calvo C. Effect of continuous positive airway pressure on ambulatory blood pressure in patients with obstructive sleep apnoea. Blood Press Monitoring 2044; 9: 193-202.
79. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 2000; 35: 144-7.
80. Engleman HM, Gough K, Martin SE, Kingshott RN, Padfield PL, Douglas NJ. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in "non-dippers". Sleep 1996; 19: 378-81.
81. Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomised placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 163: 344-8.
82. Pepperell JTC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, Davies RJ. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea. Lancet 2002; 359: 204-10.
83. Gotsopoulos H, Kelly JJ, Cistully PA. Oral appliance therapy reduces blood pressure in obstructive sleep apnea; a randomized controlled trial. Sleep 2004; 27: 934-41.
84. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Rocella EJ. National Heart, lung and Blood Institute Joint National Committee on Prevention, Detection, Evaluation and Treatment of high Blood pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.